EyePoint Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 8.33 M | $62.02 M | 0.00% | 15.29% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 6.78 M | $50.53 M | 31.05% | 12.46% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 5.75 M | $42.84 M | 51.66% | 10.56% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 5.28 M | $39.35 M | 27.10% | 9.70% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 4.14 M | $30.82 M | 3.13% | 7.60% |
| VANGUARD GROUP INC | 02/11/2025 | 3.80 M | $28.33 M | 24.77% | 6.98% |
| FEDERATED HERMES, INC. | 02/13/2025 | 3.71 M | $27.62 M | 92.73% | 6.81% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 3.57 M | $26.61 M | 287.31% | 6.56% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 3.18 M | $23.70 M | 100.00% | 5.84% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 2.14 M | $15.98 M | -13.94% | 3.94% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.66 M | $12.39 M | 36.79% | 3.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.54 M | $11.47 M | 28.34% | 2.83% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 1.54 M | $11.45 M | 48.20% | 2.82% |
| STATE STREET CORP | 02/14/2025 | 1.49 M | $11.11 M | 22.68% | 2.74% |
| PATIENT SQUARE CAPITAL LP | 02/14/2025 | 1.41 M | $10.51 M | 3.55% | 2.59% |
| ESSEX WOODLANDS MANAGEMENT, INC. | 02/13/2025 | 1.17 M | $8.72 M | -24.60% | 2.15% |
| FINEPOINT CAPITAL LP | 02/13/2025 | 1.11 M | $8.28 M | 57.07% | 2.04% |
| 5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 1.05 M | $7.82 M | 0.00% | 1.93% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 857,853 | $6.39 M | 90.08% | 1.58% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 667,594 | $4.97 M | 100.00% | 1.23% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 600,000 | $4.47 M | 100.00% | 1.10% |
| STEMPOINT CAPITAL LP | 02/14/2025 | 579,500 | $4.32 M | 100.00% | 1.06% |
| UBS GROUP AG | 02/14/2025 | 570,026 | $4.25 M | 42.09% | 1.05% |
| WOODLINE PARTNERS LP | 02/14/2025 | 501,724 | $3.74 M | 25.43% | 0.92% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 446,199 | $3.32 M | 100.00% | 0.82% |
| JPMORGAN CHASE & CO | 02/12/2025 | 395,444 | $2.95 M | 6.37% | 0.73% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 353,954 | $2.64 M | -22.56% | 0.65% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 351,348 | $2.62 M | 39.79% | 0.65% |
| ALLY BRIDGE GROUP (NY) LLC | 02/14/2025 | 348,000 | $2.59 M | 100.00% | 0.64% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 270,336 | $1.90 M | 118.13% | 0.50% |
| AXA S.A. | 02/14/2025 | 263,143 | $1.96 M | -0.16% | 0.48% |
| HSBC HOLDINGS PLC | 02/14/2025 | 257,615 | $1.92 M | 1.43% | 0.47% |
| ABRDN PLC | 01/24/2025 | 230,745 | $1.72 M | 100.00% | 0.42% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 223,641 | $1.67 M | 233.43% | 0.41% |
| ARTIA GLOBAL PARTNERS LP | 02/14/2025 | 216,700 | $1.61 M | 38.64% | 0.40% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 213,382 | $1.59 M | -67.06% | 0.39% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 206,939 | $1.54 M | -83.69% | 0.38% |
| LAURION CAPITAL MANAGEMENT LP | 02/14/2025 | 205,578 | $1.53 M | -55.31% | 0.38% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 204,260 | $1.52 M | 22.16% | 0.38% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 191,165 | $1.42 M | 33.90% | 0.35% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 183,949 | $1.37 M | 7.63% | 0.34% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 177,316 | $1.32 M | 3.23% | 0.33% |
| MYDA ADVISORS LLC | 02/13/2025 | 160,000 | $1.19 M | 60.00% | 0.29% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 137,500 | $1.02 M | -26.64% | 0.25% |
| CI PRIVATE WEALTH, LLC | 02/10/2025 | 130,662 | $5,439 | 0.00% | 0.24% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 02/07/2025 | 125,417 | $934,357 | -11.77% | 0.23% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 123,769 | $922,079 | 100.00% | 0.23% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 121,274 | $903,491 | 21.27% | 0.22% |
| BARCLAYS PLC | 02/13/2025 | 120,221 | $895,000 | -50.94% | 0.22% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2025 | 110,550 | $823,598 | -7.12% | 0.20% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
EyePoint Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 167 institutional investors and hedge funds held shares of EyePoint Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Cormorant Asset Management, LP: 8.33 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 6.78 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 5.75 M
BlackRock Funding, Inc. /DE: 5.28 M
FRANKLIN RESOURCES INC: 4.14 M
VANGUARD GROUP INC: 3.8 M
136.20% of EyePoint Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 77.63 M shares in the last 24 months. This purchase volume represents approximately $673.86 M in transactions.